Project Grant R01AT013489
- The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $178,856 Project Grant under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to conduct research aimed at developing an interpretable and predictive model for post-surgical pain (P-SP) outcomes. The project will leverage multimodal data, including functional...
- This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), will fund a research project titled "Harnessing Sleep and Biological Rhythms to Improve Postoperative Recovery" at The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH). The $453,750 award, spanning 5 years from September 1, 2025 to August 31, 2030, will support research to understand...
- The Department of the Army Medical Command awarded a $1,509,972 project grant to the Massachusetts General Hospital through the Military Medical Research and Development program. The grant will fund research from September 2022 through September 2025 to assess neuroinflammation in chronic pain using non-invasive microstructural imaging techniques. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming...
- This $421,250 Project Grant awarded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) will support research to elucidate how lifestyle factors such as diet, exercise, and social interactions shape the gut microbiome's contributions to human metabolic health. Over the 5-year grant period from September 2025 to June 2030, the research will be conducted by the President and Fellows of Harvard College. The...
- The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $3,565,780 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to develop a groundbreaking high-frequency trans-spinal magnetic stimulation (HF-TSMS) system for the non-invasive treatment of neuropathic pain. The funded project aims to create an HF-TSMS tool that can target neural pathways involved in...
- The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $1,931,124 Project Grant under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to conduct research on the link between deranged gut homeostasis and the pathogenesis of fibromyalgia. The project, running from Sep 1, 2025 to Aug 31, 2028, aims to test the hypothesis that intestinal...
- This Project Grant award of $4,649,740 from the National Institute of Neurological Disorders and Stroke (part of the National Institutes of Health) under the Drug Use and Addiction Research Programs (CFDA 93.279) is funding research to develop network-based models for understanding inter-individual differences in the progression of chronic musculoskeletal pain, using knee osteoarthritis as a case study. The research aims to: 1) Use natural language processing to annotate patient narratives and...
- This federal Project Grant award of $239,405.00, awarded by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121), supports research to investigate the neural circuit mechanisms of peripheral nerve stimulation for the treatment of trigeminal neuropathic pain. The research aims to elucidate how peripheral nerve stimulation activates the thalamic reticular nucleus, a key brain region involved in regulating...
- This $591,122 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, will fund research by the Massachusetts Institute of Technology (MIT) to decode and modulate the emotional aspect of pain. Key objectives include: Systematically characterizing autonomic responses to identify signatures for different mouse pain models. Performing in vivo imaging and...
- This federal Project Grant award, valued at $453,750.00 and effective September 1, 2025, was provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859). The award supports a research program led by The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to advance the understanding of perioperative neurocognitive disorders (PND) and their association with disruptions in...
This is a $5,318,433 Project Grant awarded by the National Institute of Neurological Disorders and Stroke (part of the National Institutes of Health) under the Drug Use and Addiction Research Programs (CFDA 93.279). The grant will fund research to investigate the role of the gut microbiome in contributing to individual differences in lumbosacral radicular pain, including pain severity, impact, and persistence after treatment. The research will leverage machine learning techniques to accurately quantify real-life activities and pain impact. The grant was awarded to The General Hospital Corporation, doing business as Massachusetts General Hospital, a renowned nonprofit academic medical center and teaching hospital of Harvard Medical School. The project will run from August 15, 2025 through July 31, 2029.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $5.3m | 8/14/25 |